Literature DB >> 3878744

Cellular immunity against Salmonella typhi after live oral vaccine.

A Tagliabue, L Nencioni, A Caffarena, L Villa, D Boraschi, G Cazzola, S Cavalieri.   

Abstract

Seventeen adult volunteers were vaccinated orally with the live attenuated Salmonella typhi mutant strain Ty21a. Their peripheral blood mononuclear cells were tested at different times after vaccination for direct cell-mediated activity against bacteria, employing a simple short-term in vitro assay. It was observed that 16/17 of the vaccinated subjects acquired the capacity to express specific cellular immunity against S. typhi which lasted from 15 days to at least 3 years. The effector cell of the in vitro antibacterial activity was preliminarily characterized as a non-adherent T3+, T8-, T4+ lymphocyte. In parallel, mice immunized orally with S. typhimurium and proving resistant to reinfection were tested employing the same in vitro assay. Also in this case peripheral and, most important, intestinal lymphocytes were able to express cellular immunity against the agent of murine typhoid. It is concluded that administration of live oral vaccine against S. typhi results in the induction of specific cellular immunity which is expressed at the peripheral and, probably, also at the intestinal level.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3878744      PMCID: PMC1577437     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  8 in total

1.  A rapid method for the isolation of functional thymus-derived murine lymphocytes.

Authors:  M H Julius; E Simpson; L A Herzenberg
Journal:  Eur J Immunol       Date:  1973-10       Impact factor: 5.532

2.  Failures with oral typhoid vaccine Ty 21a.

Authors:  B Hirschel
Journal:  Lancet       Date:  1983-04-09       Impact factor: 79.321

3.  Isolation and characterization of Gal E mutant Ty 21a of Salmonella typhi: a candidate strain for a live, oral typhoid vaccine.

Authors:  R Germanier; E Füer
Journal:  J Infect Dis       Date:  1975-05       Impact factor: 5.226

4.  A controlled field trial of live Salmonella typhi strain Ty 21a oral vaccine against typhoid: three-year results.

Authors:  M H Wahdan; C Sérié; Y Cerisier; S Sallam; R Germanier
Journal:  J Infect Dis       Date:  1982-03       Impact factor: 5.226

5.  Genetic control of in vitro natural cell-mediated activity against Salmonella typhimurium by intestinal and splenic lymphoid cells in mice.

Authors:  A Tagliabue; L Nencioni; L Villa; D Boraschi
Journal:  Clin Exp Immunol       Date:  1984-06       Impact factor: 4.330

6.  IgA-dependent cell-mediated activity against enteropathogenic bacteria: distribution, specificity, and characterization of the effector cells.

Authors:  A Tagliabue; D Boraschi; L Villa; D F Keren; G H Lowell; R Rappuoli; L Nencioni
Journal:  J Immunol       Date:  1984-08       Impact factor: 5.422

7.  Antibody-dependent cell-mediated antibacterial activity of intestinal lymphocytes with secretory IgA.

Authors:  A Tagliabue; L Nencioni; L Villa; D F Keren; G H Lowell; D Boraschi
Journal:  Nature       Date:  1983 Nov 10-16       Impact factor: 49.962

8.  Natural and antibody-dependent cell-mediated activity against Salmonella typhimurium by peripheral and intestinal lymphoid cells in mice.

Authors:  L Nencioni; L Villa; D Boraschi; B Berti; A Tagliabue
Journal:  J Immunol       Date:  1983-02       Impact factor: 5.422

  8 in total
  16 in total

1.  Functional differentiation of T cells in the intestine of T cell receptor transgenic mice.

Authors:  S D Hurst; S M Sitterding; S Ji; T A Barrett
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-15       Impact factor: 11.205

Review 2.  Immunology of gut mucosal vaccines.

Authors:  Marcela F Pasetti; Jakub K Simon; Marcelo B Sztein; Myron M Levine
Journal:  Immunol Rev       Date:  2011-01       Impact factor: 12.988

3.  Antibodies in action: role of human opsonins in killing Salmonella enterica serovar Typhi.

Authors:  Janet C Lindow; Kelly A Fimlaid; Janice Y Bunn; Beth D Kirkpatrick
Journal:  Infect Immun       Date:  2011-05-31       Impact factor: 3.441

4.  Safety, immunogenicity, and efficacy against cholera challenge in humans of a typhoid-cholera hybrid vaccine derived from Salmonella typhi Ty21a.

Authors:  C O Tacket; B Forrest; R Morona; S R Attridge; J LaBrooy; B D Tall; M Reymann; D Rowley; M M Levine
Journal:  Infect Immun       Date:  1990-06       Impact factor: 3.441

5.  Construction and characterization of a Vi-positive variant of the Salmonella typhi live oral vaccine strain Ty21a.

Authors:  S J Cryz; E Fürer; L S Baron; K F Noon; F A Rubin; D J Kopecko
Journal:  Infect Immun       Date:  1989-12       Impact factor: 3.441

6.  T- and B-cell immune responses of patients who had undergone colectomies to oral administration of Salmonella enterica serovar Typhi Ty21a vaccine.

Authors:  Jan Kilhamn; Samuel B Lundin; Hans Brevinge; Ann-Mari Svennerholm; Marianne Jertborn
Journal:  Clin Diagn Lab Immunol       Date:  2003-05

7.  Oral immunization with a Salmonella enterica serovar typhi vaccine induces specific circulating mucosa-homing CD4(+) and CD8(+) T cells in humans.

Authors:  B Samuel Lundin; Camilla Johansson; Ann-Mari Svennerholm
Journal:  Infect Immun       Date:  2002-10       Impact factor: 3.441

8.  Safety, infectivity, immunogenicity, and in vivo stability of two attenuated auxotrophic mutant strains of Salmonella typhi, 541Ty and 543Ty, as live oral vaccines in humans.

Authors:  M M Levine; D Herrington; J R Murphy; J G Morris; G Losonsky; B Tall; A A Lindberg; S Svenson; S Baqar; M F Edwards
Journal:  J Clin Invest       Date:  1987-03       Impact factor: 14.808

9.  Comparative analysis of immunological responses to oral (Ty21a) and parenteral (TAB) typhoid vaccines.

Authors:  R D'Amelio; A Tagliabue; L Nencioni; A Di Addario; L Villa; M Manganaro; D Boraschi; S Le Moli; R Nisini; P M Matricardi
Journal:  Infect Immun       Date:  1988-10       Impact factor: 3.441

10.  Antibacterial activity of human mononuclear leukocytes against Staphylococcus aureus.

Authors:  L Prokesová; D H Dung; I Trebichavský; E Formánková; V Stĕpánková; C John
Journal:  Folia Microbiol (Praha)       Date:  1994       Impact factor: 2.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.